Age: 65 years Position : Chairman of the Board , Head of M&A Committee , Head of Remuneration Committee , Member of the Audit Committee  Board member since: 2017, Chairman since June 2024 , Member of M&A Committee since 2019 ,Member of the Remuneration Committee since 2019 Number of shares : 0 

Jostein Davidsen studied at Oslo School of Economics & Administration ( Handelsakademiet ).He holds several Leadership and Board Programs & Practise Series from IMD , Lausanne Switzerland. Jostein has more than 35 years extensive international Pharma leadership experience.

He held during his career several Leading International Management positions at Nycomed before the company was acquired by Takeda Pharmaceuticals.He became a Corporate Officer at Takeda Pharmaceuticals and a Member of the Executive Commercial management team as a Head of Global Emerging Markets, based out from Zürich.

He was awarded the 2nd most successful Emerging market Leader Globally in 2014 by Scrip Pharmaceutical & Analytical journal. Jostein was later on the CEO of the Swiss based International Company Acino Pharmaceuticals, based in Zürich.He has been serving as a Management Coach for leaders within the Pharma.Today he holds several Board mandates and Advisory roles in the industry.